The Retina: Vascular Diseases I

Published on 08/03/2015 by admin

Filed under Opthalmology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 7771 times

14 The Retina: Vascular Diseases I

RETINAL VASCULAR OCCLUSIONS

The posterior ciliary circulation supplies the optic disc and choroid through the short posterior ciliary arteries and the circle of Zinn (see Ch. 17); the central retinal artery leaves the ophthalmic artery in the orbit and only supplies the capillaries on the surface of the optic disc and the retina (see Ch. 20). Retinal vascular occlusions are a common cause of visual loss especially in elderly, hypertensive, diabetic or arteriosclerotic patients. Patients usually present with sudden unilateral visual loss although this might be noticed only coincidentally some time after the initial event particularly in elderly people. All patients need a careful assessment for associated underlying systemic hypertension, diabetes or other atherogenic diseases. Subclinical cardiac and cerebrovascular disease is frequently present and patients should be investigated with these in mind as prophylactic medical or surgical treatment might be indicated to limit or prevent further systemic vascular damage.

ARTERIAL OCCLUSIONS

CENTRAL RETINAL ARTERY OCCLUSION

This is usually a disease of the elderly and is most commonly caused either by thrombosis in the retrobulbar portion of the central retinal artery or blockage of the artery by an embolus which usually originates in the heart or carotid artery. Complete occlusion may be preceded by attacks of amaurosis fugax. All patients should be screened for hypertension, diabetes, cardiac valvular and coronary artery disease and carotid atheromatous disease. Temporal arteritis usually presents as an anterior ischaemic optic neuropathy but occasionally causes a central retinal artery occlusion (CRAO) and needs to be excluded (see Ch. 17). In younger patients, the underlying aetiology is occasionally found to be an inflammatory arteritis of which polyarteritis nodosa, systemic lupus erythematosus and syphilis are perhaps the commonest causes. Spasm of the central retinal artery is an ill-defined and controversial phenomenon that occurs only in exceptional circumstances such as drug toxicity with ergot overdosage or pre-eclamptic toxaemia of pregnancy. CRAO is a rare feature of migraine.

Experimentally retinal infarction takes 1½ hours of complete arterial occlusion. Occasionally some eyes with CRAO achieve some visual recovery probably because the embolus fragments and disperses. If a patient is seen within a few hours of the initial loss of vision it is worthwhile to presume that the occlusion is embolic in nature. Working with this hypothesis attempts should be made to dislodge the embolus by massaging the globe to fluctuate intraocular pressure, giving intravenous acetazolamide or performing paracentesis of the anterior chamber to lower intraocular pressure. However, visual recovery is rare and the prognosis is generally very poor. Patients have a reduced life expectancy from vascular disease; cardiac infarction is the most common cause of death.

image

Fig. 14.7 Cilioretinal infarction with central retinal artery sparing is the converse situation to that shown in Fig. 14.5. Here, a small cilioretinal branch is occluded, thus infarcting the retina temporal to the optic disc. A frill of axoplasmic material from the viable retina is seen surrounding the cilioretinal infarct. Cilioretinal infarcts have a similar aetiology to anterior ischaemic optic neuropathy, temporal arteritis, which although it usually presents with more extensive disc infarction, must be excluded as a potential cause.

RETINAL EMBOLI

Embolization of the retinal circulation usually occurs with cholesterol or fibrin and platelet emboli from the carotid arteries, or calcific fragments from a stenosed aortic valve. Occasionally more exotic material such as talcum powder in drug addicts or fat emboli in patients with multiple fractures can be seen. Emboli may produce permanent or transient visual loss; cholesterol emboli are also frequently seen coincidentally on routine examination of an asymptomatic eye. Transient uniocular visual loss is known as amaurosis fugax and is virtually always due to embolization, whether or not emboli are actually seen on examination. Patients typically notice uniocular visual loss starting as a concentric peripheral dimming of vision or a vertical curtain coming over the eye, depending on whether the central retinal artery or a branch retinal artery is affected. Most attacks last for periods of a few minutes but may persist for 2–3 hours before vision quite rapidly returns to normal. Attacks may happen singly or in groups, sometimes occurring in clusters or showers during a day. Patients with retinal embolization have an increased risk of developing a permanent stroke over the next few months and the risk is substantially increased if the amaurosis fugax is accompanied by signs of transient cerebral ischaemia or an embolus is visible in the retina. This means that the ophthalmologist plays an important role in the management of these patients by referring them for prophylactic medical or surgical treatment to forestall the development of permanent neurological sequelae. In young patients, mitral valve prolapse or cardiac septal defects can present as amaurosis fugax. Migraine is another rare cause in young adults and may produce transient visual loss by affecting either the retinal or the choroidal circulation. The features are often atypical and more common causes need to be excluded before a diagnosis is made. Choroidal migraine produces patchy visual loss, rather like pieces missing from a jigsaw puzzle, due to involvement of the choroidal lobular circulation (see Ch. 9).

VENOUS OCCLUSIONS

Retinal venous occlusions are the commonest retinopathy after diabetes and age-related macular disease. They are classified according to whether the occlusion affects the central retinal vein or its tributaries. The early physical signs are dilatation of the affected vein, haemorrhage in the territory of the retina drained by the vein, retinal oedema, varying amounts of capillary closure and retinal ischaemia with cotton-wool spots. Venous occlusions vary considerably in their severity and the visual disability depends on the part of the retina affected, the severity of the occlusion and the amount of retinal ischaemia. Mild venous occlusions cause visual disability from retinal haemorrhage or vascular leakage and macular oedema whereas more severe lesions also produce ischaemia and retinal capillary closure and carry the risk of neovascularization.

CENTRAL RETINAL VEIN OCCLUSION

Mild central retinal vein occlusions (CRVOs) can be asymptomatic but more severe occlusions present with loss of vision due to macular oedema, ischaemia or haemorrhage, which varies from minor to severe. Features of CRVO are retinal haemorrhages which characteristically extend out to the peripheral retina, dilated retinal veins, retinal oedema and variable amounts of ischaemia. The appearance of the fundus can vary from a grossly haemorrhagic fundus with optic disc oedema, to mild forms with only a few fundal haemorrhages and mild vascular changes; this range is reflected in the initial visual symptoms and subsequent clinical sequelae.

Patients may present with nonischaemic or ischaemic occlusions but about 30 per cent of patients presenting with a nonischaemic CRVO progress to develop retinal ischaemia. Patients with the ischaemic type are more likely to have poor presenting vision (worse than 20/200), a relative afferent pupillary defect, cotton-wool spots, large areas of retinal ischaemia and extensive deep haemorrhages in all four quadrants. Significant ischaemia is defined on fluorescein angiography as more than 10 disc diameters of nonperfusion. Optic disc neovascularization is rare but ischaemic CRVO can progress to neovascularization on the iris and in the angle and eventually rubeotic glaucoma, typically about 3–4 months after the acute episode. Panretinal photocoagulation can halt iris and angle neovascularization and prevent rubeotic glaucoma. The Central Vein Occlusion Study recommended waiting until new vessels developed on the iris or angle before performing panretinal photocoagulation but some retinal specialists believe that early treatment with panretinal photocoagulation in eyes with marked ischaemia is advisable, particularly when follow-up may be difficult. Predictors of neovascularization include a relative afferent papillary defect, vision worse than counting fingers and more than 30 disc diameters of nonperfusion on fluorescein angiography. Macular grid laser photocoagulation has been shown to be ineffective for macular oedema in patients with nonischaemic CRVO although some specialists believe that young patients (aged less than 55 years) may benefit from this treatment. No treatment has yet been shown to improve the ocular prognosis.

Elderly patients with central retinal vein occlusion have an increased incidence of arteriosclerosis, smoking, hypertension and diabetes. The role of associated arterial disease in the pathogenesis remains controversial but, as the central retinal artery and vein share a common fascial sheath within the optic nerve, thickening and hypertrophy of the artery can compromise the vein’s diameter leading to obstruction. Patients often notice visual loss on waking with vision having been normal the night before and it has been postulated that lower ocular perfusion due to lower blood pressure and pulse rate and increased intraocular pressure during sleep contribute to this (see Ch. 7). CRVO is also a well recognized association of raised intraocular pressure; this is particularly important to recognize as lowering the IOP in the fellow eye may prevent a subsequent occlusion in this eye.

Hyperviscosity states can produce a similar picture to central vein occlusion from venous stasis, although a hyperviscosity retinopathy is bilateral and usually less severe. Venous occlusion must also be differentiated from low arterial pressure retinopathy (ocular ischaemic syndrome or slow flow retinopathy).

Although CRVOs are most common in those aged over 60 years, younger patients may also be affected.

In younger patients an ocular or systemic vasculitis, hyperlipidaemia and clotting abnormalities need to be excluded in addition to the other risk factors such as contraceptive pill use. CRVO can occur from inflammatory phlebitis in association with sarcoidosis or Behçet’s disease. However, most younger patients are generally well and have no associated systemic disease; the probable aetiology in these patients is a congenital vascular anomaly. In these patients involvement of the fellow eye, later development of occult systemic disease or reduced life expectancy from vascular disease is unusual.

Patients with retinal vein occlusion have an increased incidence of death from cardiac or cerebral causes. Furthermore, there is a 15 per cent risk of recurrence in the same or fellow eye over 5 years. All patients require medical investigation (Table 14.1).

image

Fig. 14.19 In the presence of gross capillary closure, 30–50 per cent of eyes develop rubeosis iridis and progress to thrombotic glaucoma. Rubeosis iridis classically appears about 3 months after the vein occlusion. In the earliest stages a fine neovascular network is seen around the pupil or the angle of the anterior chamber. This is followed by development of ectropion uveae from contraction of the neovascular membrane, further vascular proliferation, glaucoma and corneal oedema (see Ch. 8). This sequence of events can be forestalled by early panretinal photocoagulation as soon as the new vessels appear on the iris or angle; for this reason patients should be seen every month for 6 months after presentation. After treatment the rubeotic iris vessels will atrophy to leave the patient with an eye that has poor vision but is comfortable. Retinal or optic disc neovascularization is very uncommon after CRVO. Glaucomatous eyes with rubeosis and visual potential may be salvaged by a tube drainage procedure. Blind eyes can be made comfortable by topical steroid and mydriatic therapy but a proportion of these eyes will eventually have to be enucleated as blind painful eyes.

image

Fig. 14.23 The optic nerve of a patient whose eye was enucleated for thrombotic glaucoma shows gliosis and atrophy of the nerve (compare with the normal nerve see Ch. 17). The common fascial sheath of the central retinal artery and vein is demonstrated; the artery is identified by its muscular wall. A thrombus containing cholesterol crystals is lodged in the arterial lumen, the vein is pushed to one side, and there is recanalization with multiple channels.

BRANCH RETINAL VEIN OCCLUSION

Occlusion of branch retinal veins produces a similar fundus picture to that of central vein occlusion but limited to the affected area. Most branch vein occlusions occur in the temporal retina at arteriovenous crossings in patients with systemic hypertension or arteriosclerosis. Thickening of the artery leads to compression of the underlying vein within the shared fascial sheath. Branch vein occlusions at other sites may occur from an inflammatory phlebitis (see Ch. 10), with diabetes or occasionally at the rim of a deeply cupped glaucomatous optic disc where the vein bends over the rim.

Neovascularization can occur at the optic disc or peripheral retina but rubeotic glaucoma is very rare after branch retinal vein occlusion. Sectorial retinal photocoagulation is not indicated unless there is retinal neovascularization; this carries a more benign prognosis than other types of peripheral retinal neovascularization and some retinal specialists wait until vitreous haemorrhage occurs before embarking on photocoagulation. Macular grid laser has been shown to be effective in treating macular oedema due to leakage from branch vein occlusion. However, the patient’s vision commonly improves spontaneously as the vein occlusion resolves and it is worthwhile delaying treatment for 3 months and reserving treatment for patients with vision of 20/40 or worse.

Sequelae of branch retinal vein occlusion

SLOW FLOW RETINOPATHY (OCULAR ISCHAEMIC SYNDROME)

Poor arterial perfusion of the retina from severe occlusive vascular disease (e.g. Takayasu’s disease in young people, severe carotid occlusion from atheroma in older people) produces a fundus picture of dilated veins and peripheral haemorrhages, similar to that seen in mild central retinal vein occlusion but differentiated from this by a very low central retinal artery perfusion pressure. Central retinal artery pressure must be extremely low for these changes to occur; this low pressure can readily be demonstrated by pulsation or occlusion of the artery by slight digital pressure on the globe during ophthalmoscopy. Patients may present with episodic blurring or washing out of vision, sometimes precipitated by bright light, which can be differentiated from amaurosis fugax because vision is not completely lost. Severe hypoperfusion may lead to rubeosis which is difficult to manage. Carotid vessel surgery has not been shown to improve visual outcome. The role of panretinal photocoagulation in the prevention of glaucoma is controversial and is possibly only effective in the presence of capillary closure.

HYPERVISCOSITY SYNDROMES

Blood viscosity can be raised by polycythaemia, increased levels of plasma proteins from myeloma or exceptionally, by massive leucocytosis in leukaemia. Waldenstrom’s macroglobulinaemia is the most common cause of hyperviscosity. It is a myeloma in which large quantities of monoclonal IgM (the largest molecule of all plasma proteins) are produced. Patients also have weight loss, malaise, hepatosplenomegaly, Raynaud’s phenomenon, bleeding tendency and neurological signs. Although patients with hyperviscosity may develop a bilateral retinopathy of venous dilatation and peripheral haemorrhages many patients have normal fundi (apart from mild venous dilatation) in the presence of very high plasma viscosity and the presence of a retinopathy frequently correlates more with other concomitant haematological changes such as anaemia and thrombocytopenia rather than simple viscosity changes.

HYPERTENSIVE RETINOPATHY

Systemic hypertension produces changes in the choroidal, retinal and optic disc circulations; these changes depend on the severity, rapidity of onset and duration of the hypertension and the age of the patient. The branch retinal ‘arteries’ are, in fact, arterioles by histological criteria. Recent work suggests that arteriolar narrowing precedes the development of hypertension by increasing the peripheral vascular resistance and haemodynamic load. Narrowing of the arterioles reflects the intimal thickening and medial hyperplasia, hyalinization and sclerosis seen histopathologically. With accelerated hypertension necrosis of the smooth muscle in the media from ischaemia, followed by subsequent vascular dilatation and leakage of plasma into the vessel wall produces fibrinoid necrosis. Occlusion, haemorrhage and infarction follow.

The eye is the only site in the body where blood vessels can be observed directly and several attempts have been made to classify and grade the effect of hypertension on these vessels. However, it is impossible to differentiate between the early changes of hypertension and the normal ageing changes of arteriolar sclerosis: changes in the light reflex of the arteriolar wall and in arteriovenous crossing are seen in both and must be interpreted in conjunction with the age of the patient. Arterial attenuation, which may be focal or diffuse, occurs in both situations. Severe systemic hypertension of sudden onset produces a microvascular retinopathy with comparatively little change in the major arterioles; the converse is true where the rise in blood pressure has been gradual and prolonged allowing time for compensatory sclerotic changes to take place in the major retinal arteries.

RETINAL MACROANEURYSMS

Macroaneurysms of the retinal arterioles are usually seen in elderly patients with systemic hypertension; they are similar in pathology to the Charcot–Bouchard aneurysms of the cerebral circulation which are thought to be due to embolization with damage to the arterial wall. Retinal macroaneurysms tend to occur at the branching points of second or third order arterioles. They may be found either coincidentally or because they cause visual disability due to haemorrhage or leakage of lipid and macula oedema. Studies have shown that the haemorrhagic complications resolve spontaneously and do not require specific treatment but that exudative changes should be treated by photocoagulation as they may damage the fovea producing permanent visual loss. Retinal macroaneurysms must be distinguished from Leber’s miliary aneurysms (see Ch. 15) or vascular anomalies due to venous occlusions or diabetes.

RETINOPATHY OF PREMATURITY

Screening for retinopathy of prematurity (ROP) has increased in importance with the development of neonatalogy and the survival of low birthweight infants: 65 per cent of babies weighing less than 1000 g and 90 per cent of those weighing between 1000 and 1500 g can be expected to survive.

Retinal vasogenesis commences from the optic disc at 16 weeks and is completed at only 36 weeks in the nasal retina and only at term on the temporal side. Some 30–60 per cent of babies born weighing less than 1500 g develop some ROP but sight-threatening disease is confined to those infants with a gestational age of less than 31 weeks and a birthweight of less than 1500 g. It is generally accepted that ROP has multifactorial causes of which prematurity and oxygen are the most important.

The disease process can be divided into a retinal and a vitreoretinal phase and both of these phases can be divided into either an active or a nonactive cicatricial phase. Acute ROP is characterized by cessation of normal vasogenesis and the formation of a demarcation line between the vascularized and nonvascularized retina, soon to be followed by the development of a poorly differentiated vasoproliferative lesion at the demarcation line. Spontaneous regression of acute disease can happen at any stage of development and the severity of permanent cicatricial sequelae depends on the acute stage reached before regression occurs. Only 1–2 per cent of cases run the full course to total retinal detachment with spontaneous regression in the remaining 98 per cent.

STAGING AND INTERNATIONAL CLASSIFICATION

The international classification is based on three factors: (1) the degree of retinal vascular prematurity related to three retinal zones, (2) the severity of disease expressed in increasing stages from I to V and (3) the circumferential extent of disease expressed in clock-hours. The zones are centred on the optic disc with zone 1 circumscribed by an imaginary circle twice the optic disc–fovea distance (a radius of 30°), zone 2 extending as a circle demarcated by the nasal ora serrata/disc radius and temporally by the equator and zone 3 represented by the remaining temporal crescent outside zone 2. In Stages I–III the disease process is confined to the retina. Further progression involves the vitreous. Stages IVa (macula on) and IVb (macula off) represent the cicatricial phase with localized traction retinal detachment. Stage V represents end-stage disease with total retinal detachment.

The goal of screening is to identify and treat ‘threshold’ ROP. This is defined as disease at stage III (ridge with extraretinal fibrovascular proliferation) that involves zone 1 or 2 over five contiguous or eight cumulative clock-hours or the presence of ‘plus’ disease in which the arterioles are tortuous and veins engorged in the posterior pole. Argon laser photocoagulation with the indirect ophthalmoscope of the peripheral nonperfused retina should be undertaken in infants with ‘threshold’ disease as these babies have a high risk of developing cicatricial retinal detachment. Effective and economical screening can be achieved by limiting screening to infants with a gestational age of 33 weeks or less and weighing less than 1500 g. All such babies are examined at 6–8 weeks after birth and again at a gestational age of 36 weeks. Most cases of ROP develop between 32 and 44 weeks, and stage 3 occurs between 34 and 42 weeks; the more posterior (zone 1 or 2) the involvement, the more rapid and severe is the development. ROP that develops after 36 weeks is unlikely to reach stage 3, as is ROP developing in zone 3.

TRAUMATIC RETINOPATHY

The retina can be damaged by excessive exposure to light, ionizing radiation or by contusion injury. Retinal tears and perforating injuries are discussed in Chapter 12 and drug toxicity in Chapter 15.